gemcitabine has been researched along with enbucrilate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ZL; Duan, G; Huang, LS; Wan, J; Wang, CX; Yan, XQ | 1 |
| Chen, Y; He, Q; Zhang, H | 1 |
| Hou, Y; Li, C; Liu, H; Wang, Y; Zhang, L | 1 |
3 other study(ies) available for gemcitabine and enbucrilate
| Article | Year |
|---|---|
[Preparation of gemcitabine polybutylcyanoacrylate nanoparticles].
Topics: Chemistry, Pharmaceutical; Deoxycytidine; Drug Delivery Systems; Enbucrilate; Gemcitabine; Nanoparticles | 2007 |
Involvement of bleomycin hydrolase and poly(ADP-ribose) polymerase-1 in Ubc9-mediated resistance to chemotherapy agents.
Topics: Antineoplastic Agents; Bleomycin; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cisplatin; Cysteine Endopeptidases; Deoxycytidine; DNA Damage; Doxorubicin; Drug Resistance, Neoplasm; Enbucrilate; Etoposide; Female; Fluorouracil; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Poly (ADP-Ribose) Polymerase-1; Ubiquitin; Ubiquitin-Conjugating Enzymes; Vincristine | 2017 |
Comparative study on the antitumor effects of gemcitabine polybutylcyanoacrylate nanoparticles coupled with anti-human MUC1 and CA199 monoclonal antibodies on pancreatic cancer in vitro and in vivo.
Topics: Animals; Antibodies, Monoclonal; Enbucrilate; Gemcitabine; Humans; Mice; Mice, Nude; Mucin-1; Pancreatic Neoplasms | 2022 |